5 Αποτελέσματα
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn.371 filing of PCT/EP2006/011367, filed Nov. 27, 2006. PCT/EP2006/011367 claims the benefit of European Patent Application No. 05025776.5, filed Nov. 25, 2005. The disclosures of the aforementioned applications are
The present invention provides a method for the treatment of malignant neoplasias comprising the step of administering an L-phenylalanine conjugated to a beta- or alpha-emitting isotope to a subject in the need thereof. Moreover, the invention provides a method for the monitoring of the progress of
TECHNICAL FIELD
The present invention relates to a marker for determining sensitivity to an anticancer agent which is used to determine whether a cancer in a subject patient has a therapeutic response to an anticancer agent or not, and to an application thereof.
BACKGROUND ART
There are various
FIELD OF THE INVENTION
This invention relates to enteral nutritional products for cancer patients and, more particularly, to enteral nutritional products comprising high fat, low carbohydrate and an elemental amino acid profile having a selected amino acid imbalance for suppressing tumor
Background of the Invention
The present invention relates to acyl derivatives of glucosamines with amino acids or synthetic peptides, endowed with antitumor chemotherapeutic activity against transplanted tumors in animals, to pharmaceutical compositions containing said derivatives, to processes for